NCT02343250View on ClinicalTrials.gov

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2015

Conditions
Hypertension
Interventions
DRUG

Cilnidipine/Valsartan

Cilnidipine 10mg/Valsartan 160mg oral on day1 of 14day cycle

DRUG

Cilnidipine+Valsartan

Cinidipine 10mg+Valsartan 160mg oral on day1 of 14day cycle

DRUG

Cilnidipine/Valsartan

Cilnidipine 10mg/Valsartan 160mg oral on day1 of 14day cycle

DRUG

Cilnidipine+Valsartan

Cinidipine 10mg+Valsartan 160mg oral on day1 of 14day cycle

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02343250 - A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan | Biotech Hunter | Biotech Hunter